Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
A phase I study of daily afatinib, an irreversible ErbB family blocker, in combination with weekly paclitaxel in patients with advanced solid tumours. [electronic resource] by
- Suder, A
- Ang, J E
- Kyle, F
- Harris, D
- Rudman, S
- Kristeleit, R
- Solca, F
- Uttenreuther-Fischer, M
- Pemberton, K
- Pelling, K
- Schnell, D
- de Bono, J
- Spicer, J
Producer: 20160130
In:
European journal of cancer (Oxford, England : 1990) vol. 51
Availability: No items available.
|
|
5.
|
A feasibility study of sequential doublet chemotherapy comprising carboplatin-doxorubicin and carboplatin-paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma. [electronic resource] by
- Ang, J E
- Shah, R N
- Everard, M
- Keyzor, C
- Coombes, I
- Jenkins, A
- Thomas, K
- A'Hern, R
- Jones, R L
- Blake, P
- Gabra, H
- Hall, G
- Gore, M E
- Kaye, S B
Producer: 20100108
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 20
Availability: No items available.
|
|
6.
|
Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience. [electronic resource] by
- Olmos, D
- Arkenau, H-T
- Ang, J E
- Ledaki, I
- Attard, G
- Carden, C P
- Reid, A H M
- A'Hern, R
- Fong, P C
- Oomen, N B
- Molife, R
- Dearnaley, D
- Parker, C
- Terstappen, L W M M
- de Bono, J S
Producer: 20090319
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 20
Availability: No items available.
|